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Abstract 
Deceased organ donors where the cause of death is meningitis or encephalitis are a 
potential concern because of the risks of transmission of a potentially fatal infection to 
recipients. Using the UK Transplant Registry, a retrospective cohort analysis of 
deceased organ donors in the UK was undertaken to better understand the extent to 
which organs from deceased donors with meningitis and encephalitis (of both known 
and unknown cause) have been used for transplantation, and to determine the 
associated recipient outcomes. Between 2003 and 2015, 258 deceased donors with 
meningitis and encephalitis were identified and the causative agent was known in 188 
(72.9%). These donors provided 899 solid organs for transplantation (455 kidneys and 
444 other organs). The only recorded case of disease transmission was from a donor 
with encephalitis of unknown cause at time of transplantation who transmitted a fatal 
nematode infection to two kidney transplant recipients. A further 3 patients (2 liver 
and one heart recipient) died within 30 days of transplantation from a neurological 
cause (cerebrovascular accident) with no suggestion of disease transmission. Overall, 
patient and graft survival in recipients of organs from donors with meningitis and 
encephalitis were similar to those for all other types of deceased organ donor. Donors 
dying with meningitis and encephalitis represent a valuable source of organs for 
transplantation. The risk of disease transmission is low but where the causative agent 
is unknown caution is required.  
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Introduction 
The demand for organs for transplantation far exceeds supply and increasing 
consideration is being given to the use of organs from sub-optimal donors, including 
those perceived to pose a potential increased risk of disease transmission to the 
recipient (1,2). Donors who have a died as a result of meningitis or encephalitis are of 
potential concern because of the risk of transmitting life threatening meningitis or 
encephalitis to the immunocompromised recipient (2,3). This risk was highlighted by 
a recent case in the United Kingdom (UK) where an encephalitis of unknown cause 
was transmitted from the donor and killed both renal transplant recipients (4). Cases 
of meningitis and encephalitis transmission have been observed in the United States 
(US) and Europe, with the transmission often proving fatal (5-13). The risk of disease 
transmission needs to be evaluated and balanced against the potential benefit of 
providing additional donor organs for transplantation to the recipient population.   
UK guidelines from the Advisory Committee on the Safety of Blood, Tissues and 
Organs (SaBTO) (2011) state that ‘Material from cases of meningo-encephalitis for 
which no infection is identified should not be used for donation’.The guidelines also 
state that ‘if there is any possibility of acquisition of a neurotropic infection from 
abroad the donation is contraindicated owing to the risk of rabies, West Nile virus or 
other exotic neurotropic infections’. However, there is a caveat in the guidance that 
recognises there may be a clinical need for transplantation of such urgency that it is 
appropriate to consider the use of organs and tissues for life-preserving purposes from 
donors who would not otherwise be considered eligible to donate, due to a known or 
perceived risk of disease transmission   (14). SaBTO guidance also states that ‘if 
bacterial meningitis has been confirmed, but there is no visible damage or local 
infection in the organ or tissues required at retrieval, the donation of the organs, 
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tissues and cells are acceptable’ for transplantation (14). 
US guidance (2013) also states that donors dying of encephalitis without a proven 
cause should likely be avoided’ (15).  The UK and US guidance is mirrored by that 
from the Council of Europe (2015), which states that ‘if the aetiology of an active 
infection cannot be established the donor is not a suitable candidate for donation’(16).   
Despite current guidance, organs from donors where the cause of meningitis and 
encephalitis is not known continue to be used for transplantation, as clinicians balance 
the risk of donor transmitted disease against the risk of death on the waiting list whilst 
awaiting a graft. In this study we reviewed the UK experience, to better understand 
the extent to which organs from deceased donors with meningitis or encephalitis (of 
both known and unknown cause) have been used for transplantation, and to determine 
the associated recipient outcomes. 
 
Methods 
Identification of deceased donors who died of Meningitis and Encephalitis 
The UK Transplant Registry (UKTR) held by NHSBT was examined to identify 
deceased donors between 1
st
 January 2003 and 31
st
 December 2014, where the cause 
of death was meningitis and/or encephalitis, and who donated one or more organs for 
transplantation. All UK deceased donors whose cause of death was coded in the 
UKTR as ‘meningitis’ were readily identified. However, the designated codes for 
cause of death in the UKTR are limited to any one of 65 possible causes and there is 
no code for encephalitis on the registry currently, leaving the data entry team the 
option of coding cases of encephalitis as ‘meningitis’, ‘infection-type unclassified’, 
‘other’, ‘other-please specify’ and ‘unknown’ and using the free text entry to specify 
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encephalitis as the cause of death. All free text entries in the registry for donors whose 
primary cause of death was coded as ‘meningitis,’ were fully reviewed to identify if 
the infection had been recorded as viral, bacterial, was not known or was unstated, 
and whether the causal infectious agent had been recorded. For deaths coded as 
‘infection-type unclassified’, ‘other’, ‘other-please specify’ and ‘unknown’, free text 
entries were searched using the search terms ‘Meningitis’, ‘Encephalitis’, ‘Meningo-
encephalitis’, and common misspellings of these terms to identify any additional 
donors where the cause of death was meningitis/encephalitis and to find whether the 
causal agent had been identified. The information on organ donors entered into the 
UKTR is that entered at time of donation, and any subsequent changes in cause of 
death or in causative agent for meningitis or encephalitis are relayed to the recipient 
centres but not changed on the registry.  
 
Identification of potential donors who died of Meningitis or Encephalitis 
The Potential Donor Audit (PDA), held by NHSBT, is a prospectively collected 
registry of all patients aged less than 80 years who died in critical care units of all 
acute hospitals in the UK.  The PDA inclusion criteria changed over the study period, 
with the upper age limit increasing from 75 to 80 years in 2013. From 2013, 
cardiothoracic intensive care units were also included in the audit. In 2009, the PDA 
changed the wording of the questions being asked and allowed more reasons to be 
given for why potential donors did not become solid organ donors.  The PDA was 
examined to identify all non-proceeding potential donors who died of meningitis or 
encephalitis over the study period. Potential organ donors were identified in the same 
way as those in the UKTR, with cause of death coding supplemented by free-text 
searches. 
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Identification of recipients who received organs from donors who died of known 
and unknown causes of meningitis and encephalitis 
Recipients of organs from donors who died of known and unknown causes of 
meningitis/encephalitis in the UK between 1
st
 January 2003 and 31st December 2014 
were identified using the UKTR. Information on recipient survival and death censored 
graft survival was extracted from the UKTR.  
Prior to 2010, recipient centres were expected, according to UK guidance, to report 
any adverse outcomes in recipients relating directly to the organ donation process to 
NHS Blood and Transplant (NHSBT), including, in the case of donors with 
meningitis/encephalitis, transmission of the causal agent. This reporting requirement 
became mandatory when the new European Union Organ Donation Directive 
(EUODD) guidelines came into effect (2010) and was written into UK law in the 
Quality and Safety of Organs for Transplantation Regulations (2012).  
 
Statistical Analysis 
Principal univariate analyses reported deceased donor and recipient characteristics by 
donor meningitis and encephalitis status (known cause meningitis and encephalitis 
(KME), unknown cause meningitis an encephalitis (UKME), other) using 
percentages, means or median and standard deviations or interquartile ranges as 
appropriate. Univariate analysis was carried out using t-test for continuous data. 
Comparisons between groups were made using χ2–tests for categorical data, and 
unpaired difference tests for continuous data (one-way ANOVA if normality can be 
assumed, Kruskal-Wallis test otherwise).  
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Kaplan-Meier curves were used to compare death-censored graft survival and patient 
survival across donor cause of death groups. The univariate log-rank test was used to 
calculate p-values from this.  
All analyses were performed using Statistical Analysis System (SAS) (version 9.3) 
and P-values less then 0.05 were deemed to be statistically significant (17).  Human 
Leukocyte Antigen (HLA) mismatch level was defined according to UK allocation 
policy for kidneys from brain-death donors and was based on the mismatch between 
donor and recipient at the HLA-A, -B, and -DR loci: level 1 was a 000 HLA-A, -B, 
and -DR mismatch; level 2 was a 0 HLA-DR plus 0/1 HLA-B mismatch; level 3 was 
a 0 HLA-DR plus 2 HLA-B mismatch or a 1 HLA-DR plus 0/1 HLA-B mismatch; 
and level 4 was a 2 HLA-DR or a 1 HLA-DR plus 2 HLA-B mismatch’ (18). The 
United Kingdom Model for End-Stage Liver Disease (UKELD) score was used when 
assessing differences in liver recipient characteristics. This score is calculated based 
on the patient’s international normalized ratio (INR), serum creatinine, serum 
bilirubin, and serum sodium (19).  
 
Results 
Identification of donors who died from meningitis or encephalitis 
A total of 258 (2.4%) of the 11,530 deceased donors, who donated one or more 
organs for transplantation, were identified as having died of a meningitis or 
encephalitis over the 12 year study period.  Of the 258 organ donors identified, 214 
(1.9%) were directly coded by the UKTR as having died of meningitis (figure1). A 
further 44 donors were not coded as meningitis but it was clear from free text entries 
that they had died of meningitis or encephalitis/meningo-encephalitis.  Further 
analysis of free text entries in the UKTR for these donors showed that 221 (85.7%) 
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had meningitis and the remaining 37 (14.3%) had encephalitis or meningo-
encephalitis.  
There were 221 organ donors who died from meningitis of which 169 (76.5%) had a 
bacterial cause, 2 (1.4%) a viral cause. In 43 (19.5%) of cases the aetiology of the 
meningitis was unknown and in 7 (3.2%) it was unstated (figure 1). Thirty-seven 
donors died from encephalitis and/or meningo-encephalitis, for which a bacterial 
cause was thought to be responsible in 11 (29.7%), a viral cause in 6 (16.2%) and in 
20 (54.1%) of cases, the cause was unknown. Where the cause of meningitis or 
encephalitis was known, the causative infectious organism was stated in 63% of 
meningitides and 19% of encephalitides (Table 1). Most of the bacterial meningitides 
were attributed to a streptococcal or meningococcal cause.  
The UK Potential Donor Audit was scrutinized to identify potential organ donors 
aged less than 80 years with meningitis or encephalitis that did not proceed to organ 
donation and therefore were not entered on the organ donor transplant registry. 
Over the 12-year study period, a total of 692 non-proceeding potential organ donors 
died of meningitis/encephalitis and did not donate organs for transplantation. Of these 
potential donors, 84 (12%) had encephalitis and 608 (88%) had meningitis. 
Information recorded in the PDA regarding diagnosis was limited, but manual review 
of the free text entries revealed that 38 non-proceeding potential donors had 
meningitis of unknown aetiology at time of death, 35 had a bacterial cause of for 
meningitis, and one had viral meningitis. The majority of non-proceeding potential 
donors did not have a causative agent stated for their meningitis. Of those non-
proceeding potential donors with encephalitis, 25 had viral encephalitis, 22 had 
encephalitis of unknown aetiology and 4 had a bacterial cause. Again the majority of 
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non-proceeding potential donors did not have a causative agent for their encephalitis 
stated.  
Whereas the number of potential donors who died of meningitis or encephalitis was 
greater in the latter part of the 12-year study period, the number of actual organ 
donors dying of meningitis or encephalitis remained relatively constant throughout 
the study period (figure 2). Clinical details entered in the potential donor audit of why 
potential donors did not proceed to organ donation were limited. However, analysis of 
the reasons coded in the database or available in free text entries indicated that 112 
(18.7%) of the 692 potential organ donors were declined based on their cause of death 
i.e. meningitis and encephalitis.  
 
Characteristics of donors who died of meningitis and encephalitis 
The clinical characteristics of the 221 organ donors with meningitis and the 37 donors 
with encephalitis were very similar and were, therefore, combined and compared to 
those donors who died of all other causes during the study period (Table 2). Organ 
donors who died of meningitis or encephalitis were younger and more often donation 
after brain death (DBD) then donation after circulatory death (DCD) donors. They 
also, on average, donated more organs and more of the donated organs were 
transplanted. Overall, donors with meningitis or encephalitis had a lower body mass 
index (BMI), a lower incidence of hypertension and of cardiac disease, and were less 
often smokers.  
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Characteristics of recipients receiving organs from donors who died of meningitis 
and encephalitis  
The 258 organ donors with meningitis and encephalitis provided a total of 899 solid 
organs that were transplanted. These included 455 kidneys, 237 livers, 71 hearts, 44 
lungs, 7 heart and lung, 72 pancreas glands and 13 other solid organ transplants. The 
types of organs transplanted were similar in deceased donors with known and 
unknown causes of meningitis and encephalitis (data not shown). 
 
Kidney Transplant Recipients  
UK centres transplanted a total of 455 kidneys from donors who died of known and 
unknown causes of meningitis and encephalitis.  All 24 UK transplant centres 
accepted kidneys from donors with both KME and UKME (figure 3). Over the entire 
study period, these comprised 1-11% of the total number of renal transplants 
performed (figure 3). There was no clear relationship between the volume of 
transplant activity at a particular transplant centre and the proportion of transplants 
performed using kidneys from donors with KME and UKME. The clinical 
characteristics of recipients who received kidneys from donors who died with an 
unknown cause and those with a known cause (bacterial or viral) of meningitis or 
encephalitis are shown separately and are compared with the recipients of organs 
from donors without meningitis or encephalitis (Table 3). There were no major 
clinical differences between recipients who received kidneys from donors who died of 
known and unknown causes of meningitis and encephalitis. Overall recipients who 
received kidneys from donors with meningitis or encephalitis were markedly younger 
than those who received kidneys from deceased donors who died from other causes. 
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The recipients of kidneys from donors with UKME and KME received kidneys, 
which had a better HLA-match than those from donors who died from other causes. 
 
Liver Transplant Recipients  
The clinical characteristics of the 237 liver transplant recipients who received livers 
from organ donors with KME and UKME are shown in supplementary table 1 along 
with the characteristics of recipients of livers from donors who died of all other 
causes. The recipients of livers from KME donors and UKME donors were 
significantly younger than recipients of livers from donors who died of all other 
causes. Livers from UKME donors were more frequently allocated to recipients on 
the super-urgent waiting list (the most urgent category). 
 
Heart Transplant Recipients  
Over the study period 71 hearts were transplanted from donors who died of meningitis 
and encephalitis (supplementary table 2). Recipients from donors who died of 
meningitis/encephalitis were younger, and were much more likely to require a heart 
urgently in comparison to recipients of hearts from donors who died of all other 
causes (supplementary table 2).   
 
Recipient outcomes after transplantation 
Of the 899 recipients who received transplants from donors with UKME and KME 
there were 2 early deaths attributable to donor transmission of encephalitis. The donor 
was a 39-year-old male who died in hospital with a meningo-encephalitis of unknown 
aetiology. The renal recipients, males aged 67 and 42, died of encephalitis 17 days 
and 19 days respectively following transplantation. On post-mortem examination, the 
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transmitted organism was found to be the nematode infection Halicephalobus 
gingivalis. It is the first documented UK case and first documented human-to-human 
transmission of this organism, and the 6
th
, 7
th
 and 8
th
 documented cases of human 
infection. The UKTR did not include any other reports of death, graft loss or major 
morbidity secondary to disease transmission from any of the other donors with 
UKME or KME. Only one other of the 455 recipients of kidneys from donors with 
UKME or KME died within 30 days of transplantation, and death in this case was 
attributed to cardiovascular disease, giving a thirty day mortality of 0.7%, which is 
similar to the thirty-day mortality in renal transplant recipients who received kidneys 
from donors who died of all other causes (153 deaths in 19,095 recipients (0.8%)).In 
the 444 recipients of non-renal organs from donors with UKME and KME, there were 
14 deaths within 30 days (3.2% 30 day mortality rate vs. 3.7% in recipients of organs 
from donors without UKME or KME), of which 3 deaths were attributed to a 
neurological cause and in all of these this was a cerebrovascular accident (CVA). Of 
the three deaths from CVA, one recipient died of an ischemic stroke 11 days after 
receiving a liver from a donor with an unknown cause of encephalitis who also 
donated 2 kidneys for transplantation, one recipient died of a stroke (type unstated) 28 
days after receiving a liver from a donor with a unknown cause of meningitis who 
also donated 2 kidneys for transplantation, and one recipient died of a haemorrhagic 
stroke12 days after receiving a heart from a donor with E.coli meningitis who donated 
2 kidneys and a liver for transplantation. In none of these three patients was any 
mention made in the free text entries to suggest the CVAs were in any way related to 
the transmission of infection.  
Overall patient survival was significantly better in recipients of kidneys from donors 
with KME (p=0.002). After adjustment using cox proportional hazard model the 
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survival advantage was secondary to lower donor age, lower recipient age, a greater 
proportion being DBD donors and the donors possessing fewer comorbidities 
(p=0.06) (data not shown).  Death censored graft survival for recipients of kidneys 
from donors with KME was greater than that for recipients of kidneys from donors 
who died of any other cause of death, but this difference failed to reach statistical 
significance (Figure 4).  Patient and graft survival was similar for kidney recipients 
from UKME donors and recipients from donors who died from other causes.  
Death Censored graft survival and patient survival were comparable for heart and 
liver recipients from UKME and KME donors when compared to all other cause of 
death heart and liver transplant recipients (Figure 5 and supplementary figure 1). 
 
Discussion 
The present UK registry analysis was undertaken to determine the extent to which 
organs from deceased donors who died of meningitis or encephalitis were 
transplanted in the UK, and to determine the outcome of recipients who received such 
organs.  Over the 12-year study period, a total of 899 organs were transplanted from 
258 donors who died of meningitis or encephalitis. The number of actual organ 
donors who died of meningitis or encephalitis over the 12-year study period remained 
relatively constant, and all UK transplant units accepted organs from such donors for 
transplantation. In the case of kidney transplants, there was evidence that the 
threshold for accepting kidneys from donors who died of meningitis or encephalitis 
varied between centres, but such variability did not correlate with the volume of 
transplant activity undertaken by the centre.  
While donors with meningitis or encephalitis comprised only a small proportion 
(2.3%) of the total number of deceased organ donors over the study period, they made 
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an important contribution to transplant activity, leading to 455 kidney transplants and 
444 non-renal transplants.  Moreover, such donors tended to be younger with 
favourable donor characteristics and overall they donated more organs per donor. The 
majority (66%) of the entire donor cohort in this analysis who died of meningitis had 
a known cause of meningitis and therefore the use of their organs for transplantation 
was not, according to current UK guidelines, contraindicated. Nevertheless a large 
number (34%) of those who donated organs died of an unknown or unstated cause of 
meningitis or encephalitis.  Use of organs from such donors is cautioned in the UK 
guidelines, although it is recognised that their use in life saving situations may be 
appropriate. In the present study, donors with an unknown cause of meningo-
encephalitis donated not only life saving organs but most  (91%) donated at least one 
kidney for transplantation. We cannot exclude the possibility that, at least in some of 
these donors, additional reassuring clinical information relating to the aetiology of the 
meningo-encephalitis (e.g. expert opinion suspecting a bacterial cause that could not 
be proven) may have been made available to the transplanting centres, but was not 
recorded in the registry.  
In the present study, there was no recorded incidence of transmission of the causative 
agent for meningitis or encephalitis from any of the donors where the causative agent 
was identified prior to donation. It is important to appreciate that clinical decision 
making informed the use of organs from donors with meningitis or 
encephalitits/meningo-encephalitis and it cannot be assumed that if organs from the 
potential, rather than actual, organ donors with a known cause of meningitis had been 
used that they also would not have posed a risk of disease transmission. One (2.7%) 
of the 37 organ donors with encephalitis (representing one (5%) of the 20 organ 
donors with an unknown cause of their encephalitis) transmitted infection to two renal 
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allograft recipients.  In both cases the transmitted infection, which was subsequently 
shown to be the nematode H.gingivalis, was fatal.  There were no other recorded 
cases of disease transmission for patients who died of an unknown cause of 
meningitis and encephalitis. Overall, recipients of organs from donors who died as a 
result of a meningitis or encephalitis (known or unknown causes) had similar patient 
and graft survival to that observed in recipients of organs from donors who died from 
other causes. Where a bacterial cause of donor meningitis or encephalitis/ meningo-
encephalitis was identified, this information would have been available to the 
recipient transplant centres and it is likely that most, if not all, recipients of such 
organs would have received prophylactic antibiotic treatment in keeping with clinical 
guidelines. 
The number of actual organ donors with meningitis or encephalitis was around a third 
of the number of potential donors identified from the UK potential donor audit dying 
with meningitis or encephalitis but whose organs were not used for transplantation. 
This figure is considerably higher than the overall percentage of actual to potential 
organ donors identified from the UK potential donor audit (20). Unfortunately, the 
data available in the UK PDA was not sufficiently detailed to allow us to determine 
precisely why potential donors with meningitis and encephalitis did not proceed to 
become actual organ donors, but in at least 18.7% of cases the reason cited was the 
underlying cause of death, and presumably concern by recipient centres about disease 
transmission. However, it is impossible to estimate how many of these unused 
potential organ donors could have transmitted a fatal disease to recipients, and hence 
how many potential lives were saved through not using these organs for 
transplantation.  
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The findings arising from the present analysis may allow clinicians at transplanting 
centres to make a more informed decision about the risks of disease transmission 
when considering the use of organs from potential donors with meningitis and 
encephalitis.  The decision to transplant an organ from a donor with meningitis and/or 
encephalitis, especially where the cause is unknown, should be taken after fully 
informing the potential recipient of the associated risks.  
There are several published case studies, that describe examples of donor-derived 
infection causing meningitis and encephalitis in transplant recipients (5-13).  A wide 
range of pathogens responsible for such disease transmission have been implicated 
and often it had not been clear before organ transplantation that the donors had 
meningitis and encephalitis (5-13). An emerging concern in the US is the transmission 
of West Nile Virus (WNV) from affected donors to transplant recipients, which has 
been seen in 8 different clusters. Transmission of Lymphocytic Choriomeningitis 
Virus (LCMV), Balamuthia Mandirallis and Rabies have also been reported (5-13). In 
the clusters of donor derived infection of meningitis and encephalitis, a wide variety 
of causes of death of the donors were reported, ranging from urinary tract infection, 
diabetic ketoacidosis, trauma and stroke (5,9-11,21,22).  The current literature 
suggests that the risk of donor transmission of meningitis and encephalitis is 
omnipresent and exclusion of such donors, who are often relatively young and 
previously healthy, would not fully address this risk because, in reported cases, the 
cause of donor death was not always known to be meningitis and encephalitis. It was 
not possible from the analysis undertaken for the present study to determine the 
number of donors with unrecognized meningitis or encephalitis. 
There are also other limitations to the present study; encephalitis and meningo-
encephalitis were not specifically coded as a cause of death in the UKTR. Nor are the 
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definitions made clear so there may have been some lack of consistency and accuracy 
between the diagnosis of encephalitis, meningitis and meningo-encephalitis. There is 
a possibility that the numbers quoted in this paper are an underestimate of those who 
died from these causes. Attempts were made to minimize this possibility by using 
multiple search terms (and common misspellings of these), and careful review of the 
free text entries. There is a possibility that cases of disease transmission from donors 
with meningitis or encephalitis were not reported to NHSBT, as the reporting 
requirement only became part of UK law in 2012. However, over the entire study 
period NHSBT has had close oversight of all UK transplant units and it is very 
unlikely that any transmission of meningitis or encephalitis occurred without NHSBT 
being made aware of this. Moreover analysis of the causes of death in the 14 patients 
who died within 30 days after receiving organs from donors with UKME or KME 
showed that only 3 were listed as dying from neurological cause (all CVA), and in 
none of these was infection noted as a contributory cause of death.  A further 
limitation of this analysis is its applicability to the wider global transplant community. 
Given the relatively limited geographical area of the UK there is limited variation in 
infectious pathogens. Hence, in other much larger countries, such as the US, where 
different infectious agents vary geographically and by time of year, additional 
consideration should be given to the risk that donors with meningitis or encephalitis 
may pose and what organism could be causing there illness.  
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Conclusion 
Organ donors who die from meningitis and encephalitis represent a relatively small 
but important cohort of donor organs. In donors where the causative agent of 
meningitis is known to be bacterial, the risk of disease transmission is very low, 
although it is important to ensure that recipients of organs from such donors receive 
appropriate prophylactic anti-microbial therapy. For organs where the causative agent 
is not known, the risk of disease transmission is greater, and more caution should be 
exercised in the use of such organs, as highlighted in various clinical guidelines. The 
risk of potentially fatal disease transmission should, however, be balanced against the 
clinical benefit of an organ transplant and the present study provides national data that 
may help guide this decision. 
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Figure Legend 
Figure 1. Figure 1: Flow diagram for organ donors identified as dying from 
meningitis/encephalitis’ 
Figure 2. The number of non-proceeding potential organ donors with meningitis and 
encephalitis and, the number of actual organ donors with meningitis and encephalitis 
Figure 3 .Total number of deceased donor kidneys transplanted in UK renal 
transplant centres (designated A-X) from the 1
st
 of January 2003 to 1
st
 of January 
2015. 
Figure 4. Graft and Patient Survival for recipients of kidneys from organ donors who 
died of known and unknown causes of meningitis and encephalitis, and organ donors 
who died from all other causes 
Figure 5. Graft and Patient Survival for recipients of livers from organ donors who 
died of unknown and known causes of meningitis and encephalitis, and organ donors 
who died from all other causes 
Supplementary Figure 1. Graft and Patient Survival for recipients of hearts from 
organ donors who died of unknown and known causes of meningitis and encephalitis, 
and organ donors who died of all other causes 
Table 1. Causal infectious agents in organ donors who died from meningitis and 
encephalitis 
Table 2. Clinical characteristics of organ donors who died of known and unknown 
causes of meningitis and encephalitis and donors who died from all other causes 
Table 3. Clinical characteristics of kidney transplant recipients from organ donors 
who died of known and unknown causes of meningitis and encephalitis, and from 
donors who died of all other causes. 
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Supplementary table 1. Clinical characteristics of liver transplant recipients from 
organ donors who died of known and unknown causes of meningitis and encephalitis, 
and from donors who died of all other causes 
Supplementary table 2. Clinical characteristics of heart transplant recipients from 
organ donors who died of known and unknown causes of meningitis and encephalitis, 
and from donors who died of all other causes 
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